04/26/2024
3:25 PM | Elevation Oncology (Filer)
| Form ARS | |
04/26/2024
3:20 PM | Elevation Oncology (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Elevation Oncology (Filer)
| Form DEF 14A | |
04/09/2024
3:26 PM | Elevation Oncology (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
04/05/2024
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:14 AM | Elevation Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/06/2024
6:00 AM | Elevation Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:40 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:28 PM | Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:16 PM | Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
3:21 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/20/2024
3:48 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:42 PM | Elevation Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
02/14/2024
3:45 PM | Elevation Oncology (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
3:32 PM | Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A | |
01/23/2024
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
3:57 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
01/22/2024
3:35 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:24 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/22/2024
8:02 AM | Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
01/22/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:24 PM | Elevation Oncology (Subject)
Qiming U.S. Healthcare GP II, LLC (Filed by)
| Form SC 13G/A | |
01/09/2024
8:07 AM | Elevation Oncology (Subject)
Empery Asset Management, LP (Filed by)
| Form SC 13G | |
01/05/2024
6:40 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/22/2023
3:30 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:42 PM | CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:01 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
6:15 AM | Elevation Oncology (Filer)
| Form 424B5 | |
08/03/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
3:29 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:26 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/14/2023
3:17 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:15 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:12 PM | CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:13 PM | Elevation Oncology (Issuer)
Hu Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:15 PM | Elevation Oncology (Issuer)
Walsh Colin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/21/2023
3:06 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:30 PM | Elevation Oncology (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13D/A | |
06/08/2023
3:30 PM | Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G | |
06/05/2023
6:00 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
4:15 PM | Elevation Oncology (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
05/15/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
